Assessed degree of alignment between investments made by Corporate Venture Capital affiliates of pharmaceutical companies and the firms’ core strategic interests, as part of a project by TEConomy Partners for PhRMA titled “Strengthening Biopharmaceutical Innovation: The Growing Role of Corporate Venture Capital.”[gview file=”https://tbed.org/wp-content/uploads/2018/11/PhRMA-CVC-Report.pdf”]